longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AstraZeneca (AZN) Receives a Buy from Berenberg Bank

Tip Ranks
Sep 10, 2026 at 02:05 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca today and set a price target of £160.00. According to TipRanks, Hector is a 4-star analyst with an average return of 4.7% and a 57.25% success rate. Hector covers the Healthcare sector, focusing on stocks such as AstraZeneca, Sanofi, and Merck & Company. In addition to Berenberg Bank, AstraZeneca also received a Buy from Goldman Sachs’s Rajan Sharma in a report issued yesterday. However, on September 8, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).

Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca today and set a price target of £160.00.

According to TipRanks, Hector is a 4-star analyst with an average return of 4.7% and a 57.25% success rate. Hector covers the Healthcare sector, focusing on stocks such as AstraZeneca, Sanofi, and Merck & Company.

In addition to Berenberg Bank, AstraZeneca also received a Buy from Goldman Sachs’s Rajan Sharma in a report issued yesterday. However, on September 8, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).

Login to unlock52characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
  • Feb 10, 2026 at 08:30 AMAfter investing $18.5 billion to partner with Stone Group, AstraZeneca's earnings per share are expected to increase by …
  • Nov 11, 2025 at 01:51 PMConsolidating its position as the "largest heavyweight stock" in the UK market, pharmaceutical giant Astrazeneca's stock…
  • Jul 29, 2025 at 07:44 AMStrong sales of anti-cancer drugs, AstraZeneca's Q2 revenue increased by 12% year-on-year, exceeding expectations | Fina…

Related Stocks

AstraZeneca

AstraZeneca

USAZN

+0.64%

AstraZeneca PLC

AstraZeneca PLC

UKAZN

Sanofi

Sanofi

USSNY

LongbridgeAI